Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) said Friday it’s made some inroads with its financials in 2024, removing its going concern designation as...
Relmada Therapeutics (Nasdaq: RLMD) announced Thursday it was shifting away from its previous focus on depression treatments and psychedelics, after acquiring two new Phase 2 drug...
Last week, Greenlane Holdings Inc. (Nasdaq: GNLN) told investors that revenue dropped dramatically when the company delivered its financial results for 2024. The company announced a...
The Massachusetts Cannabis Control Commission inched closer to allowing social consumption lounges in the state, as commissioners met Thursday hammered out key details from business relationships...
Minnesota marijuana regulators have more than 3,500 business license applications to sift through in coming months, including up to 2,100 potentially for dispensary operators and another...
Hawaii lawmakers are reportedly giving up the ghost on legalizing adult-use marijuana this year, but they still want a significant expansion of the state’s medical cannabis...
Las Vegas-based Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) this week reported a net loss of $47.8 million for the full 2024 calendar year, down...
A study testing a low-dosage LSD treatment for adult attention-deficit/hyperactivity disorder (ADHD) didn’t pan out as planned. A new article in JAMA (Journal of American Medical...
Canadian edibles company City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) announced that the remaining balance of units available for sale in its private...
Florida’s First District Court of Appeal has upheld a state formula requiring medical marijuana operators to pay around $1.3 million in biennial license renewal fees,...